UPEXI, INC. current report, Q2 FY2026

Full document

UPEXI, INC. Form 8-K Summary

Business Context and Reporting Period

UPEXI, INC. (UPXI) filed a Current Report on Form 8-K dated June 21, 2026, reporting the entry into a Material Definitive Agreement. The Company is incorporated in Delaware and trades on the NASDAQ. The report details a private placement transaction with an existing institutional accredited investor.

Key Financial Metrics and Transaction Details

The Company entered into a Securities Purchase Agreement to raise capital through a private placement. Key transaction metrics include:

  • Total Aggregate Purchase Price: $19,542,634.54
  • Securities Issued:
    • 5,250,000 shares of Common Stock at $1.59652 per share.
    • Pre-funded warrants to purchase up to 6,992,300 shares of Common Stock at $1.59631 per warrant.
  • Payment Method: The purchase price was paid in full via the retirement and cancellation of $19,542,634.54 of outstanding principal under a Secured Convertible Note due January 9, 2028.
  • Debt Reduction: The outstanding principal balance of the Note was reduced from $35,961,975 to $16,419,340.46.
  • Transaction Costs: No placement agents or brokers were engaged; no fees are payable.

Material Changes Versus Prior Period

This filing represents a discrete capital event rather than a periodic financial performance report. The primary material change is the reduction of the Company's debt load by approximately $19.5 million and the corresponding increase in equity and pre-funded warrant obligations. The filing does not provide comparative revenue, profit, or cash flow data for the period.

Guidance, Outlook, and Risks

Management Commentary and Covenants: The Company agreed to file a registration statement within 30 days of closing to cover the resale of the Shares and Pre-Funded Warrant Shares. The agreement includes customary representations, warranties, and indemnification provisions.

Risks and Contingencies:

  • Beneficial Ownership Limitations: Issuance of Shares and Pre-Funded Warrants is subject to a 9.99% beneficial ownership limitation for the Purchaser (aggregated with affiliates and the Note). Any consideration exceeding this limit is delivered as Pre-Funded Warrants.
  • Exercise Limitations: Pre-Funded Warrants are exercisable immediately but are subject to a 4.99% (or 9.99% upon election) beneficial ownership cap.
  • Liquidity: The securities were issued under Section 4(a)(2) and Rule 506(b) exemptions and are not registered for public resale until the registration statement becomes effective.

Investor Verification Checklist

  • Verify the remaining principal balance of the Secured Convertible Note ($16,419,340.46) and its interest rate terms.
  • Confirm the effective date of the registration statement for the resale of the newly issued securities.
  • Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and liquidated damages provisions.
  • Assess the dilution impact of the 5,250,000 shares and 6,992,300 pre-funded warrant shares on existing shareholders.
  • Check for any subsequent filings regarding the Company's cash position post-transaction.